Wednesday, 27 September 2023

Week 424 Review - Optibiotix saves what would have been a rubbish week

Not a great week across most of the portfolio, but a 3.5p rise in OPTI:Optibiotix meant it was a great week overall, with the deficit between cost and value reducing by £8,341 to £88,182 and total portfolio value going back above £100k to £104,370.

In a reversal of last week when GAW:Games Workshop was Share of the Week and OPTI:Optibiotix worst performer, this week GAW is the worst performer, losing most of the gains following the great results and dropping by 8%. Quite upsetting!

ANTO:Antofagasta has been edging towards profitability, but a 5% drop saw it go 7% down this week.

SBTX:SkinBioTherapeutics lost last week's gains and dropped 5% in my biggest holding.

OPTI:Optibiotix had a great week after news its products are going to be stocked in Boots, climbing 36% in my cheapest holding and 4% in my most expensive holding. I'm still a long, long way down, but a bit more news flow like this should help narrow the deficit.

Here's the ISA and shares portfolio after week 8 of year 9.

Weekly Change
Cash £165.89 +£0.78
Portfolio cost £93,364.33 +£0
Portfolio sell value
(bid price-commission)
£48,729.04 (-47.8%) +£3,821.54
Potential profits £2,247.21 +£601.26
Yr 9 Dividends £15.95 +£0
Yr 9 Interest £1.25 +£0.78
Yr 9 Profit from sales £0 +£0
Yr 9 proj avg monthly profit £2.44 (0.0%) +£0.14
Total Dividends £11,927.38 +£0
Total Interest £3.18 +£0.78
Total Profit from sales £17,298.53 +£0
Average monthly cash profit £294.73 (5.4%) -£0.69
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance 44% +0%

78p interest appeared, so much excitement there. Value and potential profits are up more than last week's drops thanks to OPTI:Optibiotix.


Better than last week is the most appropriate thing to say.


What are the chances of not going below the trend line for a while? How long can we last above it?

The SIPP looks like this after week 408 overall and week 44 of year 8.




Weekly Change
Cash £158.47
+£23.68
Portfolio cost £96,787.56
+£0
Portfolio sell value
(bid price - commission)
£53,860.42 (-44.4%) +£4,517.09
Potential profits £3,737.01
+£791.60
Yr 8 Dividends £276.76
+£23.40
Yr 8 Interest £4.26
+£0.28
Yr 8 Profit from sales -£9,597.85
+£0
Yr 8 proj avg monthly profit -£929.85 (-17.0%) +£24.01
Total Dividends £14,419.54
+£23.40
Total Interest £4.51
+£0.28
Total Profit from sales £10,835.90
+£0
Average monthly cash profit £256.38 (4.7%) -£0.37
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance 37% +0%

A £23 dividend came from RIO:Rio Tinto, and a whopping 28p interest. Value and potential profits well up thanks to OPTI:Optibiotix.


Still very similar to the ISA. I probably need to do something about that at some point.


Also very similar to the ISA.

The trading account looks like this after week 374 overall and week 10 of year 8.




Weekly Change
Cash£281.80
+£0
Portfolio cost£1,794.51
+£0
Portfolio sell value
(bid price - commission)
£1,174.88(-34.5%)+£2.79
Potential profits£0
+£0
Year 8 Dividends£8.56
+£0
Year 8 Interest£0
+£0
Year 8 Profit£283.99
+£0
Yr 8 proj avg monthly profit£126.77(+84.8%)-£14.09
Dividends£68.66
+£0
Interest£0.03
+£0
Profit from sales-£646.70
+£0
Average monthly cash profit-£6.70(-4.5%)+£0.02
(Sold stocks profit + Dividends
- Fees / Months)

A flat week for the trading account, up by just £2.


Still looking a bit promising.


Still just below the trend line but following it upwards.

OPTI:Optibiotix and PBX:Probiotix results next week. (I only know that because I'm writing this on Wednesday and they've already come out!). I won't say anything about hopes because it's pointless now I've seen them, but let's see the state of the portfolio on Friday.

No comments:

Post a Comment